Our Founder Mikko Turunen had the opportunity to present our company at Finnish Biotech and Investors meeting yesterday. Thank you for the excellent event #healthcap #innovestorgroup #finnish-industry-investment-ltd
RNatives
Biotechnology
Kuopio, Northern Savonia 164 followers
Next generation gene therapy company with innovative nuclear microRNA-technology for cardiovascular disease treatment
About us
RNatives is a platform company utilizing the novel biology of nuclear microRNAs to modulate gene expression of desired target genes. Our current focus is to upregulate endogenous VEGFA-gene. By upregulating cell´s own VEGFA by small RNA, diseases such as myocardial ischemia and peripheral artery disease can be treated. VEGFA upregulation in the affected tissue leads to neovascularization and recovery from the disease condition. RNatives propriety platform technology is based on years of academic research published by Turunen et al.
- Website
-
https://www.rnatives.com/
External link for RNatives
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Kuopio, Northern Savonia
- Type
- Privately Held
Locations
-
Primary
Get directions
Microkatu 1R
Kuopio, Northern Savonia 70210, FI
Employees at RNatives
Updates
-
I am attending Bio International convention 2024 at San Diego and representing RNatives Inc. We are a platform company developing RNA drugs which regulate target genes at transcriptional level. Current indications are cardiovascular disease, oncology, and neurodegenerative disease but have technology that allows expanding to other indications as well. I'm looking forward to meeting investors and pharmaceutical companies to discuss the exciting opportunities these novel RNA drugs offer. #BIO2024 https://lnkd.in/durG6wJ6
-
This first PhD thesis from RNatives describes RNA activation by nuclear miRNAs and their applications. The public defence is streamed, so those who can't participate in person are welcome to follow the event in Teams!
Novel microRNA could support the treatment of heart attack and ischemic stroke. The doctoral defence of Pia Laitinen, MSc, in Kuopio and online on 8 Sept, 2023. https://lnkd.in/d7xm9e4p RNatives
Doctoral defence of Pia Laitinen, MSc, 8 Sept 2023: Novel microRNA could support the treatment of heart attack and ischemic stroke
uef.fi